Abstract Approximately one-third of the mammalian genome is composed of highly repeated DNA sequences, of which the two major families, the long and short interspersed nucleotide elements (LINEs and SINEs), are represented in humans by L1 and Alu elements respectively. Both types of element are considered to be retrotransposable and to play significant roles in genomic function and evolution. The majority of inserted elements are truncated and often rearranged relative to full-length elements; usually, such retrotransposed sequences are flanked by target-site duplications of various lengths and contain 3Ј polyA tracts, common characteristics of retrotransposal integration. Retrotransposal integrations of Alu and L1 sequences into biologically important genes appear to play significant roles in some human diseases. Most of the inserted sequences that cause human diseases seem to belong to one or a few subsets of each type of retrotransposon, suggesting that only a few active elements can function as templates for retrotransposition. Integrations observed in oncogenes and in tumor suppressor genes may participate in carcinogenesis by altering the activity of the affected genes. The exact mechanism of these events is unclear; however, retrotransposal integration may be a general mechanism of mutation in humans.
Introduction
The mammalian genome contains several families of repeated DNA sequences, some of which appear to be transposable elements. Retrotransposal integrations of sequences such as Alu and L-1 into biologically important genes appear to play significant roles in some human genetic diseases. Retrotransposons are a specific group of movable genetic elements, structurally and functionally related to retroviruses, that transpose by way of an RNA intermediate; i.e., the element is transcribed to RNA, reverse-transcribed to DNA, and reintegrated elsewhere in the genome.
Eukaryotic retrotransposons are of two general types, Class I and Class II (Fanning and Singer 1987) . The coding regions of Class I elements, such as Ty in yeast or copia in Drosophila, are flanked by long terminal repeats (LTRs) and contain reverse transcriptase-and/or integrase-related sequences that possibly initiate their own retrotransposition. There is no apparent DNA sequence specificity for host integration sites although some preference has been noted (Wilson and Young 1975) . Class I retrotransposal elements are very similar to retroviruses, but the viruses possess envelope-protein genes to help them move from one cell to another. Reverse transcription of retroviruses and LTR-retrotransposons is an evolutionarily conserved process (Telesnitsky and Goff 1993) . During integration, characteristic sequence changes occur in both the viral DNA and the host DNA: two nucleotides are deleted at each end of the viral DNA, and four to six base pairs of host DNA are duplicated at the integration site.
Class II retrotransposons do not contain LTRs, have polyadenylic acid (polyA) or A-rich sequences at the 3Ј ends, and are flanked by target-site duplications of various lengths. In addition, these elements have at least one open reading frame (ORF) that is similar to the reverse transcriptases of retroviruses and class I retrotransposal elements (Xiong and Eickbush 1990; Doolittle et al. 1989) . Class II elements can be subdivided into sequence-specific and non-sequence-specific groups. The insertion mecha-nism of the R2 from Bombyx mori and the mitochondrial group II introns al1 and al2 from Saccharomyces cerevisiae implicate target site-primed reverse transcription at a sequence-specific single-strand break (Luan and Eickbush 1995; Moran et al. 1995) . The most numerous transposable genetic elements in mammals are the short and long interspersed nucleotide elements (SINEs and LINEs), represented in the human genome by Alu and L1. Class II retrotransposons, such as L1, and other elements, such as Alu and processed pseudogenes, are considered to move by retrotransposition and lack LTRs and target-site duplications of specific lengths; however, Class II retrotransposons may encode their own reverse transcriptases. This characteristic differentiates them from Alu sequences and processed pseudogenes (Temin 1985) . Evidence is convincing that both Alu and L1 have been spread by insertion throughout the human genome over time through retrotransposition, wherein new copies of active elements can be reinserted into the genome at new locations. Depending on its genomic location, the new element may disrupt the normal expression of a gene and result in disease.
Insertion mutations of L1 elements in human diseases
L1, a common family of repetitive sequences in the human genome, is considered to be a transposable element that can be transcribed into RNA, transcribed reversely into cDNA, and then reintegrated into genomic DNA. About 10 5 copies of L1 sequence are present in all mammalian genomes, comprising roughly 5% of genomic DNA (Fanning and Singer 1987) . They are up to 7 kilobases long, flanked by target-site duplications that vary from 5 to 15 bases. Unlike retroviral transposons, they carry no long terminal repeats (LTRs), but A-rich regions, usually preceded by polyadenylation signals, are present at their 3Ј ends. A consensus human L1 sequence constructed from genomic L1 sequences (Scott et al. 1987 ) comprises 6.0␣ kb and contains a 5Ј untranslated region (5'UTR) with an internal promoter (Swergold 1990) , two long open reading frames (ORF-1 and ORF-2), and a 3'UTR. ORF-1 encodes a 40-kDa RNAbinding protein, but its precise function is unknown (Holmes et al. 1992) . ORF-2 contains a region which is highly homologous to retroviral reverse transcriptase and RNase H (Hattori et al. 1989; Loeb et al. 1986; Xiong and Eickbush 1990) . These features indicate that L1 elements may be "nonviral retrotransposons" (Schwarz-Sommer et al. 1987) , which transpose though an RNA intermediate with reverse transcriptase activity, in a mechanism similar to that postulated for generating pseudogenes (Sharp 1983 ). However, because most L1 elements are heterogeneously truncated from their 5Ј ends (up to 95% in mammals; Schwarz-Sommer et al. 1987 ) and some contain internal rearrangements, it is extremely difficult to identify a structure or sequence which may still function as a transposon. Kazazian et al. (1988) documented evidence that some L1 elements in the human genome are retrotransposable, when they detected de novo insertion of a truncated L1 element into exon 14 of the Factor VIII gene on the X chromosome in two patients with hemophilia A. Each of these insertions contained a 3Ј portion of the L1 sequence; one was composed of a 3.8-kb truncated L1 sequence followed by a 57-bp polyA tract, creating an A-rich target-site duplication of at least 12 base pairs of the Factor VIII sequence. The other insertion was composed of a 2.3-kb 3Ј end of the L1 sequence, flanked by an A-rich target-site duplication of at least 13 nucleotides. However, this L1 sequence contained an internal rearrangement. On the basis of its unique 3Ј trailer sequence, the inserted element was closely related to members of the Ta subset of the L1 family (Skowronski and Singer 1986) . The full-length precursor (LRE1) to one of the factor VIII insertions was identified on chromosome 22 (Dombroski et al. 1991 ) and shown to contain the two ORFs predicted by the L1 consensus sequence. ORF1 encoded a protein of unknown function in a transient expression assay (Holmes et al. 1992 ); ORF2 encoded a protein with reverse transcriptase activity in a yeast assay system .
Two groups have reported insertions of L1 sequence into the dystrophin gene that resulted in Duchenne muscular dystrophy (DMD). An insertion identified in exon 48 of the dystrophin gene by Holmes et al. (1994) comprised a total of 1968␣ bp, including 1401␣ bp of truncated and rearranged L1 element followed by a 37-bp polyA tail; 530␣ bp of non-L1 sequence flanked the 3Ј end of the element. A perfect 12-to 15-bp target-site duplication of sequence from exon 48 surrounded the entire insertion. Since the 3Ј non-L1 sequence of this insertion showed no obvious homologies with other known sequences, it was designated a "unique sequence component" (USC). Analysis of genomic DNA from normal individuals revealed that the USC was adjacent to the progenitor L1 element in the genome. It appears that read-through transcription resulted in an L1-USC transcript capable of retrotransposition. The L1 sequence inserted into this patient's dystrophin gene (dystrophin L1) was shown to belong to the Ta subset of the L1 family, and therefore was closely related to the L1 sequence inserted into the Factor VIII gene mentioned before (Factor VIII L1). However, since the full-length progenitor of the Factor VIII L1, LRE1, differed in eight nucleotides from the dystrophin L1, LRE1 was not the precursor in this case. LRE2, the actual progenitor, was identified on chromosome 1q using the USC of dystrophin L1. Narita et al. (1993) reported evidence of retrotransposition of L1 into the dystrophin gene of two Japanese brothers with DMD. In these patients the dystrophin gene was disrupted by insertion of a truncated L1 sequence into exon 44. The 606-608␣ bp L1 fragment was identical to the inverse complement of the 3Ј portion of the Ta subset of L1 elements (Skowronski and Singer 1986) . The insertion lay within an A-T rich region in the dystrophin gene, and its second ORF was conserved; however, no target-site duplication was created and two nucleotides were deleted from the target site in the exon. Exon 44 of the transcript was skipped during splicing, an event that would shift the coding frame and lead to early termination of translation.
We ourselves reported disruption of the APC gene in a colon carcinoma, caused by a somatic insertion of an L1 element into the last exon of this gene (Miki et al. 1992 ). The 750-bp inserted sequence contained a 3Ј portion of the L1 consensus sequence; the first fifth of the insertion was almost identical to the inverse component of the L1 consensus, and the central part of the insertion was highly homologous to the 3Ј portion of the L1 consensus. The last fifth was composed of a polyadenylation signal and a subsequent 180-base polyA tract. Furthermore, since we observed an AT-rich, 8-bp target-site duplication without deletion of any APC sequence, retrotransposal insertion of an active L1 sequence was suspected as the cause of this somatic mutational event. Morse et al. (1988) reported yet another somatic insertion of an L1 sequence into a human gene. In that case, the rearranged L1 element was inserted between coding exons 2 and 3 of c-myc in a human breast carcinoma. This evidence suggested that somatic rearrangement caused by the L1 insertion, by activating the c-myc protooncogene, represented an important contributor to breast carcinogenesis in this patient.
Insertion mutations of Alu elements in human diseases
Alu elements constitute a specifically human family of interspersed repetitive sequences. They are mobile elements, with copy numbers in excess of 500,000 within the human genome . Mobilization of Alu elements is thought to occur through RNA polymerase III-derived transcription in a retrotransposition process (Rogers 1983) . Consensus Alu sequences are approximately 280␣ bp long (Fuhrman et al. 1981; Willis 1993) , and consist of two similar but distinct monomers linked by an oligod(A) tract of variable length. Alu elements, which are derived from structural RNA (Ullu and Tschudi 1984) , are flanked by short direct repeats of host DNA at integration sites in the genome.
We have reported a case of retrotransposal integration of an Alu element into a breast cancer susceptibility gene, BRCA2, of a breast-cancer patient (Miki et al. 1996) . In this novel germline event, insertion of the Alu element into exon 22 resulted in alternative splicing that skipped this exon. The presence of a 64-bp polyA tract and an 8-bp target-site duplication, which is a common characteristic of retrotransposal integration of mobile elements into staggered single-strand nicks (Deininger 1989) , implied that retrotransposal insertion of a transcriptionally active Alu element had caused an inactivating mutation. Furthermore, the sequence corresponding to the insertion site was ATrich, in keeping with the hypothesis that Alu elements preferentially integrate into AT-rich regions (Daniels and Deininger 1985) . The sequence inserted into BRCA2 in this patient was highly homologous to the consensus sequence of the conserved Alu subfamily (Fig.␣ 1) (Matera et al. 1990a) ; however, the middle portion of the insertion was identical to a sequence of the HS Alu subfamily, which is considered to be of relatively recent evolutionary origin (Batzer and Deininger 1991) . Hence, the origin of the inserted Alu element is not clear. In any event, the skipping of exon 22 in the BRCA2 transcript would shift the coding frame and lead to early termination of translation.
Four other groups have reported disease-causing inactivation of human genes due to retrotransposal integration of Alu elements. In the first example, a de novo insertion of an Alu sequence was found within exon 5 of the factor IX gene in a patient with severe hemophilia B (Vidaud et al. 1993 ). The inserted Alu element was 322␣ bp long, lay in the sense direction, and interrupted the reading frame at glutamic acid 96 of the mature factor IX protein, resulting in an inframe stop codon within the inserted sequence. This alteration of reading frame probably caused the disease. The inserted sequence differed from the HS Alu family only by one additional adenine residue, was flanked by perfect 15-bp duplications of the target-site sequence, and contained a pure polyA tract of at least 78 residues at the 3Ј end. The direct repeats were not A-T rich; however, the sequence surrounding the repeats consisted predominantly of A and T residues. Furthermore, the sequence of the direct repeats, 5Ј-GAN-3Ј, is a highly specific target site for insertion of elements from the HS subfamily (Matera et al. 1990b) . Muratani et al. (1991) identified insertion of an Alu element that disrupted exon 2 of the ChE gene in a patient with acholinesterasemia. The inserted element was 342␣ bp long, including a polyA tract of 38␣ bp, and was flanked by 15-bp target-site duplications at both junctions; no mutation was present in the original ChE gene sequence. This inserted element showed 93% homology with the evolutionarily most recent human Alu consensus sequence (Britten et al. 1988 ). These results suggested that the Alu insertion in this patient might represent a retrotransposal mechanism. The insertion had occurred in both alleles of the proband and was inherited in the patient's family. Two of the four patients studied in this family were homozygous for the ChE mutation and possessed no serum ChE activity; the two heterozygous patients had half the normal level of ChE activity. Insertion of the Alu element appeared to lead to loss of function of the ChE gene. Wallace et al. (1991) reported a de novo insertion of an Alu repetitive element into an intron of the NF1 gene, resulting in alternative splicing that skipped a downstream exon and consequently shifted the reading frame. The 320-bp Alu element was inserted 44␣ bp upstream of exon 6, terminating in exon 7, and lay in the opposite orientation to that of the NF1 gene. It included a polyA tract and was flanked by 3-13-bp direct repeats (precise lengths were not determined due to the polyA tract). The integration site included an A/T stretch of 26␣ bp. This Alu sequence was most highly homologous to the subfamily known as HS-1, which is considered to be transcriptionally active and the most recent Alu subgroup known to be capable of expansion in the genome.
Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant condition characterized by elevation of serum calcium, hypocalciuria, and nonsuppressed parathyroid hormone (PTH). Neonatal severe hyperparathyroidism (NSHPT) is considered an autosomal-recessive disorder characterized by marked elevation in serum calcium and PTH levels, skeletal demineralization, and parathyroid cellular hyperplasia that can be lethal without parathyroidectomy. Although the clinical features of these disorders are different, inactivating mutations of the calcium-sensing receptor (CASR) gene at 3q13.3-21 have been detected in some families that exhibit both FHH and NSHPT, suggesting a molecular relationship between the two conditions. Janicic et al. (1995) identified insertion of an Alu element within exon 7 of the CASR gene in FHH and NSHPT patients from the same family. The inserted Alu element was 383␣ bp long, contained an exceptionally long polyA tract (92-94␣ bp), and was in opposite orientation relative to the CASR gene. The insertion created a direct repeat of a 15-bp sequence, without any deletion of CASR. Individuals with FHH in that family were heterozygous, and some cases of NSHPT were homozygous for the insertion mutation.
The Mlvi-2 locus, containing a putative oncogene involved in the induction of thymic lymphomas in rats (Tsichlis et al. 1983) , was originally defined as one of at least five common regions for proviral integration of Moloney murine leukemia virus in this species. In a human B-cell lymphoma, one allele of the human homologue of the Mlvi-2 locus was found to be rearranged due to the insertion of an Alu element (Economou-Pachis and Tsichlis 1985). The (Quentin 1988) ; the AluHS consensus is derived from the recently formed subfamily (Batzer and Deininger 1991) . Sequences for the Alu elements inserted into genes encoding neurofibromin (ALU NF1), factor IX (ALU HB7), Mlvi-2 (ALU MLVI), calcium-sensing receptor (ALU CAR), cholinesterase (ALU CHE), and BRCA2 product (ALU BRCA2) are shown below the consensus sequences. Identical nucleotides are indicated by dashes, absent nucleotides by dots inserted Alu sequence had a polyA tail at the 3Ј end and was flanked by an 8-bp direct repeat. Since no normal tissue was available from the patient with this lymphoma, whether the insertion was a somatic or germline event could not be determined.
Evidence for at least one more Alu retrotransposition causing inactivation of a human gene was reported in two patients with Huntington's disease (HD), a late-onset autosomal dominant neuropsychiatric disorder. Alu insertions were identified in genomic DNA which showed complete cosegregation with the disease in both patients' families, but insertions were not found in 1000 unrelated HD controls (Goldberg et al. 1993) . However, as the sites of insertion were not within the HD gene itself (Huntington's Disease Collaborative Research Group 1993) it is not clear whether the observed insertion was a direct cause of the disease in these two families.
Other pathogenic mechanisms involving Alu elements
Reintegrated Alu sequences can play roles in human genetic diseases in three ways: (1) by de novo retrotransposition of an Alu sequence into genes as already described; (2) by splice-mediated insertion of an Alu sequence into mRNA; or (3) by homologous recombination that produces deletions and/or chromosomal rearrangements.
Gyrate atrophy of the choroid and retina (GA) is an autosomal recessive chorioretinal degeneration caused by deficiency of ornithine d-aminotransferase (OAT). In studies of OAT mutations, an allele whose mature mRNA showed a 142-nucleotide insertion at the junction of sequences from exons 3 and 4 was discovered (Mitchell et al. 1991) . The inserted sequences corresponded to the complement of the right half of an Alu element; a single Alu element normally is present in OAT intron 3 (between exons 3 and 4) oriented in the direction opposite to OAT. A cytosine to guanine transversion of the Alu in intron 3 had created a new donor splice site, activating a cryptic acceptor splice site at its 5Ј end and resulting in splice-mediated insertion of an Alu fragment into the mature ornithine daminotransferase mRNA.
Alport syndrome is a mainly X-linked hereditary disease of basement membranes characterized by progressive renal failure, deafness, and ocular lesions. The a3(IV) and a4(IV) collagen genes are involved in the less frequent autosomal recessive form of this disorder. Knebelmann et al. (1995) detected a mutant allele of COL4A3 whose transcripts were disrupted by a 74-bp insertion at the junction of exons 4 or 5 and 6. This insertion derived from an antisense Alu element in intron 5, which activated a cryptic acceptor splice site within the Alu sequence. This mutation always segregated with disease in the family. Similar donor site-creating mutations have been found in intron 2 of -globin (Treisman et al. 1983; Chen et al. 1984; Dobkin and Bank 1985) and in the human proto-oncogene c-rel (Brownell et al. 1989 ).
Deletions of genes due to homologous recombination between two Alu elements have been detected in genes encoding the LDL receptor (Lehrman et al. 1985) , -hexosaminidase α-chain (Myerowitz and Hogikyan 1987) , α-globin (Nicholls et al. 1987) , and adenosine deaminase (ADA) (Markert et al. 1988 ). Additionally, a sexchromosome rearrangement in a human XX male, caused by Alu-Alu recombination, was reported (Rouyer et al. 1987 ).
Insertions of transposons into genes of other mammalian species
An intracisternal A particle (IAP), a member of an abundant family of murine transposable elements, is an endogenous retroviral-like DNA element in mice. Insertion of an IAP was found within the coding region of the oncogene c-mos in mouse plasmacytoma (Rechavi et al. 1982) ; the rearranged c-mos gene in this tumor was actively transcribed and possessed transforming activity. Furthermore, a somatic insertion of a transposable element showing approximately 60% homology to L1 elements was identified in the 5Ј flanking region of the c-myc gene in a canine transmissible venereal tumor (Katzir et al. 1985) . Target-site duplication and a polyA tail suggested that the insertion had occurred as a retrotransposal event in this dog.
In mice, a dominant mutation of the Fu gene is related to a kinky tail, and homozygotes for mutated Fu alleles exhibit deafness, other neurological symptoms, and urogenital defects. Vasicek et al. (1997) detected two dominant mutations that resulted from insertions of IAP retrotransposons into the murine Fu gene; both led to complete or partial absence of wild-type products.
The reeler mouse shows neurological symptoms that include ataxia and tremors. In this mutant strain, Takahashi et al. (1996) found that exon-skipping of the reeler gene caused a 220-bp deletion in the transcript that disrupted the normal reeler product. The skipped exon contained an inserted element composed of the full-length murine L1 sequence.
Mice homozygous for the spastic mutation (spa) suffer from a complex motor disorder. The glycine receptorsubunit gene (Glrb) maps to the same region of mouse chromosome 3 as spa, and Glrb mRNA is markedly reduced in brains of spa mice. Two groups of investigators have documented an insertion of a 7.1-kb L1 element in intron 6 of Glrb that caused exon skipping (Kingsmore et al. 1994; Mulhardt et al. 1994) .
Hereditary renal carcinoma in the Eker rat is an example of a Mendelian dominant predisposition to a specific cancer, and the Eker mutation is tightly linked to the tuberous sclerosis (Tsc2) gene. Kobayashi et al. (1995) showed that the Tsc2 gene in the Eker rat was disrupted by germline insertion of an approximately 5-kb DNA fragment thought to be an L1 sequence, resulting in aberrant RNA expression.
Discussion
Table␣ 1 summarizes reports of mammalian genes whose inactivation by retrotransposal integration has led to disease. Of the seven cases on the list with L1 retrotransposal insertion, five were germline and the others were somatic events. Both somatic insertions of L1 elements involved inversion of part of the L1 sequence, while four of the six mammalian germline L1 insertions discussed [four in humans, two in mice; spa and reeler -the details of the human L1 insertion described by Bakker and Omenn (unpublished) are not known] had the expected collinear organization. Moreover, six of the seven L1 insertions listed in Table␣ 1 are members of the Ta subset, suggesting that this subset predominates among active elements. However, each of those six insertions differed in sequence and in truncation or rearrangement pattern. Four were rearranged relative to the L1 consensus sequence, three of them in two blocks; in all three of those cases the first block was inverted. The fourth rearrangement consisted of three blocks, with the first and third being inverted. The sequence inserted into a dystrophin gene in the Japanese family cited earlier, which was one of the L1 insertions without rearrangement, corresponded to the inverse complement of the 5Ј-truncated L1 sequence (Narita et al. 1993) ; this insertion lacked a target-site duplication, and two nucleotides of the dystrophin sequence were deleted.
The L1 element is common in all mammalian genomes; however, active L1 elements that can transpose appear to be rare. Two specific human L1 elements (L1.2 and LRE2) are the likely precursors of disease-producing insertions. L1.2 and LRE2 autonomously retrotranspose into chromosomal DNA at high frequencies, and that efficiency of retrotransposition requires the presence of conserved regions of the ORF1 and ORF2 products. However, the actual number of L1 elements that are capable of retrotransposition is still unknown. Recently, Sassaman et al. (1997) isolated 13 full-length elements, including three L1s capable of retrotransposition, by means of a selective screening strategy to enrich for active L1 sequences. On the basis of their data, they estimated that the average diploid human genome contains 30-60 active L1 elements.
In recent years a number of different functions have been described for Alu elements, and it has been learned that Alu elements can play several roles in human genetic disease. As already mentioned, homologous recombination between Alu elements resulting in chromosomal rearrangements, splice-mediated insertion mutations involving intronic antisense Alu sequences, or de novo retrotransposition of Alu sequences into genes can inactivate critical processes. The frequency or significance of mutations resulting from each type of event is unknown. This review has highlighted retrotransposal insertions of Alu sequence known to be factors in several different human diseases. Figure 1 compares the sequences of six inserted Alu sequences with the Alu consensus and the Alu HS-family sequence. Although each of the six insertions differs in sequence, four (ALU NF1, ALU HB7, ALU MLVI, and ALU CAR) are thought to belong to the HS Alu family, which is the most recent subfamily of transposable Alu sequences. The Alu sequence within the cholinesterase gene (ALU CHE) showed a high degree of homology with the human Alu consensus sequence of the most recent evolutionary branch (class VI). The inserted Alu element in the BRCA2 gene showed a high degree of homology with the conserved Alu subfamily, which is considered to be older than the HS Alu subfamily.
The majority of Alu retrotranspositions have been completed; the process continues only in the youngest subfami- Table 1 Inactivation of human genes due to retrotransposal integration lies, and is still a rare event. Because most Alu elements scattered in the human genome are truncated at their 5Ј-ends, they are considered to have lost their ability to expand further. In addition, most of the Alu sequences involved in reported insertion mutations belong to the Alu HS subfamily. These observations support the "master gene" model of Alu evolution; i.e., only a few "master" Alu elements are able to produce new retrotransposons (Deininger et al. 1992) .
The exact mechanism of retrotransposition and the biological function(s) of mobile genetic elements are still far from clear. However, we have considerable evidence that repetitive elements such as L1 and Alu are capable of transposing through retrotranspositional events, and in some cases such events have resulted in human disease states. Insertion of retrotransposons in fact may be a general mechanism of mutation in humans, and it is likely that additional reports of its contribution to human disease will be forthcoming. It will be of interest to determine the frequency with which transposable-element-mediated inactivation of human genes occurs in somatic or germline cells, and discover whether inherited or environmental factors influence that frequency.
